Identification of small molecule inhibitors of penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus for the therapeutics of bacterial infection
Cellular and Molecular Biology · 31.03.2024 · 70 (3) · 40-47
DOI: 10.14715/cmb/2024.70.3.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Biology, online erschienen am 31.03.2024. Verfasst von Anwer Razique. Beteiligte Einrichtung: Department of Pathology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia . razainuddin@imamu.edu.sa. Hauptthemen laut MEDLINE: Penicillin-Binding Proteins, Methicillin-Resistant Staphylococcus aureus, Molecular Docking Simulation, Xanthones. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The penicillin binding protein 2a (PBP2a) is a key enzyme associated with bacterial cell wall synthesis and bacterial infection. Therefore, targeting PBPa2 offers a promising approach for the therapeutics of bacterial resistance and infection. This study presents a comprehensive analysis of alpha-mangostin as a potential inhibitor of PBPa2. Molecular docking simulations revealed a strong binding affinity between alpha-mangostin and PBP2a, with an affinity score of -6.01 kcal/mol. Notably, alpha-mangostin formed a preferential hydrogen bond with THR216 of PBP2a, alongside several other polar and hydrophobic interactions. ADME and Toxicity predictions indicated that alpha-mangostin possesses favourable pharmacokinetic properties, suggesting its potential as a therapeutic agent. PASS analysis further highlighted its broad range of favourable biological properties. SwissTargetPrediction analysis reinforced these findings, indicating alpha-mangostin's association with various biological processes. Cell toxicity assays demonstrated that alpha-mangostin had no significant impact on the viability of HEK-293 cells, suggesting its potential safety for further development. The IC50 value for alpha-mangostin was found to be 33.43µM. Fluorescence-based binding assays showed that alpha-mangostin effectively inhibited PBP2a activity in a concentration-dependent manner, supporting its role as an inhibitor. In conclusion, the results suggest alpha-mangostin as a promising candidate for inhibiting PBP2a. Further, extensive studies are warranted to explore its clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia . razainuddin@imamu.edu.sa.
Zitieren
APA
Razique, A. (2024). Identification of small molecule inhibitors of penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus for the therapeutics of bacterial infection. Cellular and Molecular Biology, 70(3), 40-47. https://doi.org/10.14715/cmb/2024.70.3.6
Vancouver
Razique A. Identification of small molecule inhibitors of penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus for the therapeutics of bacterial infection. Cellular and Molecular Biology. 2024;70(3):40-47. doi:10.14715/cmb/2024.70.3.6
BibTeX
@article{Razique2024,
author = {Razique, Anwer},
title = {Identification of small molecule inhibitors of penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus for the therapeutics of bacterial infection},
journal = {Cellular and Molecular Biology},
year = {2024},
volume = {70},
number = {3},
pages = {40--47},
doi = {10.14715/cmb/2024.70.3.6}
}
EUVIMED